Home  >  Products  >  A2LD1 (AIG2-like domain 1 ) Blocking Peptide (the N terminal of A2LD1)(100ug)
A2LD1 (AIG2-like domain 1 ) Blocking Peptide (the N terminal of A2LD1)(100ug)

A2LD1 (AIG2-like domain 1 ) Blocking Peptide (the N terminal of A2LD1)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-A2LD1 Antibody (ARP67922_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP67922
Size: 100ug
Weight: 16kDa
Gene: 87769
Format: Lyophilized powder
Target: The protein encoded by this gene aids in the proteolytic degradation of crosslinked fibrin by breaking down isodipeptide L-gamma-glutamyl-L-epsilon-lysine, a byproduct of fibrin degradation. The reaction catalyzed by the encoded gamma-glutamylaminecyclotransferase produces 5-oxo-L-proline and a free alkylamine. Two transcript variants encoding the same protein have been found for this gene.
Alternative names: GGACT
See Full Product Listings >